These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36938123)

  • 21. Patient awareness, willingness, and barriers to point-of-care hepatitis C screening in community pharmacy.
    Brewer A; Hanna C; Eckmann L; Schadler A; Divine H
    J Am Pharm Assoc (2003); 2018; 58(4S):S69-S72.e1. PubMed ID: 30006188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons.
    Springer SA; Nijhawan AE; Knight K; Kuo I; Di Paola A; Schlossberg E; Frank CA; Sanchez M; Pankow J; Proffitt RP; Lehman W; Pulitzer Z; Thompson K; Violette S; Harding KK;
    BMC Infect Dis; 2022 Apr; 22(1):380. PubMed ID: 35428213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacy-Based Interventions to Increase Use of HIV Pre-exposure Prophylaxis in the United States: A Scoping Review.
    Zhao A; Dangerfield DT; Nunn A; Patel R; Farley JE; Ugoji CC; Dean LT
    AIDS Behav; 2022 May; 26(5):1377-1392. PubMed ID: 34669062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of Hepatitis C Virus Infections Among Users of Human Immunodeficiency Virus Pre-exposure Prophylaxis.
    Tabatabavakili S; Aleyadeh W; Cerrocchi O; Janssen HLA; Hansen BE; Bogoch II; Feld JJ;
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):674-681. PubMed ID: 33737225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceptability and feasibility of a pharmacist-led HIV pre-exposure prophylaxis (PrEP) program in the Midwestern United States.
    Havens JP; Scarsi KK; Sayles H; Klepser DG; Swindells S; Bares SH
    Open Forum Infect Dis; 2019 Oct; 6(10):. PubMed ID: 31412131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education.
    Mason JO; Noble GR; Lindsey BK; Kolbe LJ; Van Ness P; Bowen GS; Drotman DP; Rosenberg ML
    Public Health Rep; 1988; 103(3):255-60. PubMed ID: 2836879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and Proof of Concept of a Web-Based Questionnaire to Identify Patients at Risk for HIV and HCV Infection.
    García-Ruiz de Morales AG; Vivancos MJ; Lázaro J; Romero Hernández B; Mateos B; Pérez-Elías P; Herrero Delgado M; Villanova Cuadra L; Moreno S; Martínez-Sanz J; Pérez-Elías MJ
    Biomedicines; 2024 Aug; 12(8):. PubMed ID: 39200310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bundling Rapid Human Immunodeficiency Virus and Hepatitis C Virus Testing to Increase Receipt of Test Results: A Randomized Trial.
    Frimpong JA; Shiu-Yee K; Tross S; D'Aunno T; Perlman DC; Strauss SM; Schackman BR; Feaster DJ; Metsch LR
    Med Care; 2020 May; 58(5):445-452. PubMed ID: 32040038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attitudes about community pharmacy access to HIV prevention medications in California.
    Koester KA; Saberi P; Fuller SM; Arnold EA; Steward WT
    J Am Pharm Assoc (2003); 2020; 60(6):e179-e183. PubMed ID: 32665097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
    Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
    Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
    Sangani P; Rutherford G; Wilkinson D
    Cochrane Database Syst Rev; 2004; (2):CD001220. PubMed ID: 15106156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementing a collaborative practice agreement for HIV pre-exposure prophylaxis in the primary care setting.
    Lee LC; Pollak BA; Coffey CP
    J Am Pharm Assoc (2003); 2023; 63(1):383-388. PubMed ID: 36244883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C screening in a community pharmacy setting: Patient perspective.
    Pegump KN; Nichols RE; Polgreen LA; Veach SR; Crowner AB; Witry MJ
    J Am Pharm Assoc (2003); 2023; 63(4S):S78-S82. PubMed ID: 36804712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage.
    Bottero J; Boyd A; Gozlan J; Carrat F; Nau J; Pauti MD; Rougier H; Girard PM; Lacombe K
    Open Forum Infect Dis; 2015 Dec; 2(4):ofv162. PubMed ID: 26668814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of a Collaborative HIV and Hepatitis C Screening Program in Appalachian Urgent Care Settings.
    Burrell CN; Sharon MJ; Davis SM; Wojcik EM; Martin IBK
    West J Emerg Med; 2018 Nov; 19(6):1057-1064. PubMed ID: 30429942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of HIV pre-exposure prophylaxis during the preconception, antepartum and postpartum periods at two United States medical centers.
    Seidman DL; Weber S; Timoney MT; Oza KK; Mullins E; Cohan DL; Wright RL
    Am J Obstet Gynecol; 2016 Nov; 215(5):632.e1-632.e7. PubMed ID: 27448959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project.
    Dong BJ; Lopez M; Cocohoba J
    J Am Pharm Assoc (2003); 2017; 57(4):510-515.e2. PubMed ID: 28602784
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.